Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATTRACT-52: Advancing TTR Testing and Risk-Based Amyloidosis Cardiac Screening in Primary Care - The Ordu Pilot Study

NCT07238426 is registered in ClinicalTrials.gov with Kotyora Family Medicine Health Management and Education Association as lead sponsor.

NCT NCT07238426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07238426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATTRACT-52: Advancing TTR Testing and Risk-Based Amyloidosis Cardiac Screening in Primary Care - The Ordu Pilot Study
Lead sponsor
Kotyora Family Medicine Health Management and Education Association
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 1, 2025
Completion date
October 31, 2026
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis, transthyretin amyloidosis